{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:16:33Z","timestamp":1793049393242,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"DOI":"10.1038\/s41587-026-03298-8","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:03:03Z","timestamp":1790586183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lipid nanoparticles optimized for large RNA cargo and tissue targeting enhance in vivo genome editing"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6841-6924","authenticated-orcid":false,"given":"Songtao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-1813","authenticated-orcid":false,"given":"Tyler","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5772-3269","authenticated-orcid":false,"given":"Lauren","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick X. Z.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8704-1952","authenticated-orcid":false,"given":"Ziyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5105-102X","authenticated-orcid":false,"given":"Jingan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Savguira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Luozhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8827-0609","authenticated-orcid":false,"given":"Muye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon K.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-9143","authenticated-orcid":false,"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"3298_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41580-023-00697-6","volume":"25","author":"L Villiger","year":"2024","unstructured":"Villiger, L. et al. CRISPR technologies for genome, epigenome and transcriptome editing. Nat. Rev. Mol. Cell Biol. 25, 464\u2013487 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3298_CR2","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","volume":"187","author":"M Pacesa","year":"2024","unstructured":"Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076\u20131100 (2024).","journal-title":"Cell"},{"key":"3298_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"3298_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"3298_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/hum.2023.053","volume":"34","author":"F Chemello","year":"2023","unstructured":"Chemello, F., Olson, E. N. & Bassel-Duby, R. CRISPR-editing therapy for Duchenne muscular dystrophy. Hum. Gene. Ther. 34, 379\u2013387 (2023).","journal-title":"Hum. Gene. Ther."},{"key":"3298_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1186\/s12967-024-05957-3","volume":"22","author":"W Xu","year":"2024","unstructured":"Xu, W., Zhang, S., Qin, H. & Yao, K. From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine. J. Transl. Med. 22, 1133 (2024).","journal-title":"J. Transl. Med."},{"key":"3298_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ymthe.2024.01.015","volume":"32","author":"A Leonard","year":"2024","unstructured":"Leonard, A. & Tisdale, J. F. A new frontier: FDA approvals for gene therapy in sickle cell disease. Mol. Ther. 32, 264\u2013267 (2024).","journal-title":"Mol. Ther."},{"key":"3298_CR8","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"3298_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 6, 53 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3298_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat. Commun. 10, 4439 (2019).","journal-title":"Nat. Commun."},{"key":"3298_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman, J. L., Raguram, A., Newby, G. A. & Liu, D. R. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat. Biotechnol. 38, 620\u2013628 (2020).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"3298_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/mt.2009.258","volume":"18","author":"B Dong","year":"2010","unstructured":"Dong, B., Nakai, H. & Xiao, W. Characterization of genome integrity for oversized recombinant AAV vector. Mol. Ther. 18, 87\u201392 (2010).","journal-title":"Mol. Ther."},{"key":"3298_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"SM Ryu","year":"2018","unstructured":"Ryu, S. M. et al. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat. Biotechnol. 36, 536\u2013539 (2018).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR15","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkv601","volume":"43","author":"DJ Truong","year":"2015","unstructured":"Truong, D. J. et al. Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res. 43, 6450\u20136458 (2015).","journal-title":"Nucleic Acids Res."},{"key":"3298_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","volume":"30","author":"DB Kohn","year":"2023","unstructured":"Kohn, D. B., Chen, Y. Y. & Spencer, M. J. Successes and challenges in clinical gene therapy. Gene Ther. 30, 738\u2013746 (2023).","journal-title":"Gene Ther."},{"key":"3298_CR17","doi-asserted-by":"publisher","first-page":"e2307796121","DOI":"10.1073\/pnas.2307796121","volume":"121","author":"CA Tsuchida","year":"2024","unstructured":"Tsuchida, C. A., Wasko, K. M., Hamilton, J. R. & Doudna, J. A. Targeted nonviral delivery of genome editors in vivo. Proc. Natl Acad. Sci. USA 121, e2307796121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"3298_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"3298_CR20","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"F Polack","year":"2020","unstructured":"Polack, F. et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3298_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"Lindsey Baden","year":"2021","unstructured":"Baden, L. indsey et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3298_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","volume":"19","author":"P Kazemian","year":"2022","unstructured":"Kazemian, P. et al. Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components. Mol. Pharm. 19, 1669\u20131686 (2022).","journal-title":"Mol. Pharm."},{"key":"3298_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa2510209","volume":"393","author":"Julian Gillmore","year":"2025","unstructured":"Gillmore, J. ulian et al. Nexiguran ziclumeran gene editing in hereditary ATTR with polyneuropathy. N. Engl. J. Med. 393, 1375\u20131386 (2025).","journal-title":"N. Engl. J. Med."},{"key":"3298_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301067120","volume":"120","author":"L Zheng","year":"2023","unstructured":"Zheng, L., Bandara, S. R., Tan, Z. & Leal, C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. Proc. Natl Acad. Sci. USA 120, e2301067120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404555121","volume":"121","author":"A Garaizar","year":"2024","unstructured":"Garaizar, A. et al. Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments. Proc. Natl Acad. Sci. USA 121, e2404555121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee, S., Kon, E., Sharma, P. & Peer, D. Endosomal escape: a bottleneck for LNP-mediated therapeutics. Proc. Natl Acad. Sci. USA 121, e2307800120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR27","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","volume":"19","author":"HH Ly","year":"2022","unstructured":"Ly, H. H., Daniel, S., Soriano, S. K. V., Kis, Z. & Blakney, A. K. Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach. Mol. Pharm. 19, 1892\u20131905 (2022).","journal-title":"Mol. Pharm."},{"key":"3298_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3298_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309472120","volume":"120","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc. Natl Acad. Sci. USA 120, e2309472120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409572122","volume":"122","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery. Proc. Natl Acad. Sci. USA 122, e2409572122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR32","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","volume":"37","author":"L Miao","year":"2019","unstructured":"Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174\u20131185 (2019).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"3298_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ymthe.2023.02.009","volume":"31","author":"SY Yu","year":"2023","unstructured":"Yu, S. Y. et al. A luciferase reporter mouse model to optimize in vivo gene editing validated by lipid nanoparticle delivery of adenine base editors. Mol. Ther. 31, 1159\u20131166 (2023).","journal-title":"Mol. Ther."},{"key":"3298_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2835-2","volume":"587","author":"JM Wolter","year":"2020","unstructured":"Wolter, J. M. et al. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature 587, 281\u2013284 (2020).","journal-title":"Nature"},{"key":"3298_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting, K., Williams, C. & Horsthemke, B. Angelman syndrome\u2014insights into a rare neurogenetic disorder. Nat. Rev. Neurol. 12, 584\u2013593 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"3298_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","volume":"377","author":"B Binici","year":"2025","unstructured":"Binici, B., Rattray, Z., Zinger, A. & Perrie, Y. Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined in vitro and preclinical perspective. J. Control. Release 377, 162\u2013173 (2025).","journal-title":"J. Control. Release"},{"key":"3298_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58523-w","volume":"16","author":"MHY Cheng","year":"2025","unstructured":"Cheng, M. H. Y. et al. Liposomal lipid nanoparticles for extrahepatic delivery of mRNA. Nat. Commun. 16, 4135 (2025).","journal-title":"Nat. Commun."},{"key":"3298_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"3298_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber, H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310, 173\u2013186 (2001).","journal-title":"Clin. Chim. Acta"},{"key":"3298_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202417097","volume":"37","author":"Y Xue","year":"2025","unstructured":"Xue, Y. et al. Lipid nanoparticles enhance mRNA delivery to the central nervous system upon intrathecal injection. Adv. Mater. 37, 2417097 (2025).","journal-title":"Adv. Mater."},{"key":"3298_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw0730","volume":"11","author":"D Cao","year":"2025","unstructured":"Cao, D. et al. Lipid nanoparticles for mRNA delivery in brain via systemic administration. Sci. Adv. 11, eadw0730 (2025).","journal-title":"Sci. Adv."},{"key":"3298_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim, J., Eygeris, Y., Ryals, R. C., Jozi\u0107, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428\u2013447 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"3298_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","volume":"55","author":"D Loughrey","year":"2022","unstructured":"Loughrey, D. & Dahlman, J. E. Non-liver mRNA delivery. Acc. Chem. Res. 55, 13\u201323 (2022).","journal-title":"Acc. Chem. Res."},{"key":"3298_CR45","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1073\/pnas.82.17.5742","volume":"82","author":"J Bentz","year":"1985","unstructured":"Bentz, J., Ellens, H., Lai, M. Z. & Szoka, F. C. On the correlation between HII phase and the contact-induced destabilization of phosphatidylethanolamine-containing membranes. Proc. Natl Acad. Sci. USA 82, 5742\u20135745 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3298_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01690-3","volume":"9","author":"X Bao","year":"2024","unstructured":"Bao, X. et al. Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside. Signal Transduct. Target. Ther. 9, 13 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3298_CR47","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pt.2020.07.009","volume":"36","author":"KM Vendrely","year":"2020","unstructured":"Vendrely, K. M., Kumar, S., Li, X. & Vaughan, A. M. Humanized mice and the rebirth of malaria genetic crosses. Trends Parasitol. 36, 850\u2013863 (2020).","journal-title":"Trends Parasitol."},{"key":"3298_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101470","volume":"33","author":"D Stone","year":"2025","unstructured":"Stone, D. et al. Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice. Mol. Ther. Methods Clin. Dev. 33, 101470 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3298_CR49","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.adk9428","volume":"384","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. In vivo editing of lung stem cells for durable gene correction in mice. Science 384, 1196\u20131202 (2024).","journal-title":"Science"},{"key":"3298_CR50","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/s41565-025-02045-5","volume":"20","author":"S Dong","year":"2025","unstructured":"Dong, S. et al. A modular mRNA platform for programmable induction of tumour-specific immunogenic cell death. Nat. Nanotechnol. 20, 1856\u20131870 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"3298_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-026-03099-z","author":"A Marks","year":"2026","unstructured":"Marks, A. et al. mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-026-03099-z (2026).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526\u2013543 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"3298_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct. Target. Ther. 7, 166 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3298_CR54","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. 19, 1409\u20131417 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"3298_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","volume":"20","author":"L Xue","year":"2025","unstructured":"Xue, L. et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nat. Nanotechnol. 20, 132\u2013143 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"3298_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50619-z","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).","journal-title":"Nat. Commun."},{"key":"3298_CR57","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653\u20131663 (2025).","journal-title":"Nat. Mater."},{"key":"3298_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mattod.2025.11.032","volume":"92","author":"S Dong","year":"2026","unstructured":"Dong, S. et al. Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration. Mater. Today 92, 140\u2013150 (2026).","journal-title":"Mater. Today"},{"key":"3298_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-026-02555-0","author":"F Gong","year":"2026","unstructured":"Gong, F. et al. Amino acid-derived ionizable lipids enable inhaled base editing for therapeutic gene correction in the lung. Nat. Mater. https:\/\/doi.org\/10.1038\/s41563-026-02555-0 (2026).","journal-title":"Nat. Mater."},{"key":"3298_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10213","volume":"6","author":"M Schlich","year":"2021","unstructured":"Schlich, M. et al. Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles. Bioeng. Transl. Med. 6, e10213 (2021).","journal-title":"Bioeng. Transl. Med."},{"key":"3298_CR61","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1039\/D1BM01454D","volume":"10","author":"E \u00c1lvarez-Benedicto","year":"2022","unstructured":"\u00c1lvarez-Benedicto, E. et al. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA). Biomater. Sci. 10, 549\u2013559 (2022).","journal-title":"Biomater. Sci."},{"key":"3298_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.bb.14.060185.001235","volume":"14","author":"SM Gruner","year":"1985","unstructured":"Gruner, S. M., Cullis, P., Hope, M. & Tilcock, C. Lipid polymorphism: the molecular basis of nonbilayer phases. Annu. Rev. Biophys. Biophys. Chem. 14, 211\u2013238 (1985).","journal-title":"Annu. Rev. Biophys. Biophys. Chem."},{"key":"3298_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004747","volume":"3","author":"VA Frolov","year":"2011","unstructured":"Frolov, V. A., Shnyrova, A. V. & Zimmerberg, J. Lipid polymorphisms and membrane shape. Cold Spring Harb. Perspect. Biol. 3, a004747 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"3298_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112298","volume":"211","author":"J Kobierski","year":"2022","unstructured":"Kobierski, J., Wn\u0119trzak, A., Chachaj-Brekiesz, A. & Dynarowicz-Latka, P. Predicting the packing parameter for lipids in monolayers with the use of molecular dynamics. Colloids Surf. B 211, 112298 (2022).","journal-title":"Colloids Surf. B"},{"key":"3298_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11883-022-00986-z","volume":"24","author":"A Hurley","year":"2022","unstructured":"Hurley, A. & Lagor, W. R. Treating cardiovascular disease with liver genome engineering. Curr. Atheroscler. Rep. 24, 75\u201384 (2022).","journal-title":"Curr. Atheroscler. Rep."},{"key":"3298_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12642","volume":"7","author":"FP Pankowicz","year":"2016","unstructured":"Pankowicz, F. P. et al. Reprogramming metabolic pathways in vivo with CRISPR\/Cas9 genome editing to treat hereditary tyrosinaemia. Nat. Commun. 7, 12642 (2016).","journal-title":"Nat. Commun."},{"key":"3298_CR67","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","volume":"39","author":"T Rothgangl","year":"2021","unstructured":"Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949\u2013957 (2021).","journal-title":"Nat. Biotechnol."},{"key":"3298_CR68","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0169-409X(02)00145-X","volume":"54","author":"S Ferrari","year":"2002","unstructured":"Ferrari, S., Geddes, D. M. & Alton, E. W. F. W. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. 54, 1373\u20131393 (2002).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3298_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1165\/rcmb.2001-0004OC","volume":"27","author":"AS Ramalho","year":"2002","unstructured":"Ramalho, A. S. et al. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 27, 619\u2013627 (2002).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"3298_CR70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1165\/rcmb.2016-0301PS","volume":"56","author":"D Alapati","year":"2017","unstructured":"Alapati, D. & Morrisey, E. E. Gene editing and genetic lung disease. Basic research meets therapeutic application. Am. J. Respir. Cell Mol. Biol. 56, 283\u2013290 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"3298_CR71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"3298_CR72","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-025-08877-4","volume":"642","author":"CW Fell","year":"2025","unstructured":"Fell, C. W. et al. Reprogramming site-specific retrotransposon activity to new DNA sites. Nature 642, 1080\u20131089 (2025).","journal-title":"Nature"},{"key":"3298_CR73","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1016\/j.cell.2024.06.020","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons. Cell 187, 4674\u20134689 (2024).","journal-title":"Cell"},{"key":"3298_CR74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"3298_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03298-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03298-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03298-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:03:04Z","timestamp":1790586184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03298-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":75,"alternative-id":["3298"],"URL":"https:\/\/doi.org\/10.1038\/s41587-026-03298-8","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.D. and B.L. are inventors on a University of Toronto invention disclosure (CID00040) covering the ionizable lipids described in this study. B.L. serves as a scientific advisor to CybernaX Biotechnologies and DualityBio and as a consultant to AbbVie and Lila Sciences. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}